The mechanistic target of rapamycin (mTOR) pathway is now recognised as a critical regulator of immunological responses within the TME, coordinating tumor cell metabolism, immune suppression, and inflammatory signalling [155]. This evidence concerns the gene MTOR and neoplasm.